Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019
by from Morbidity and Mortality Weekly Report (MMWR) on (#4VQ59)
The Food and Drug Administration approved tafenoquine for prophylaxis of malaria and antirelapse therapy.